Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2012 by Poznan University of Medical Sciences.
Recruitment status was  Not yet recruiting
University of California, Davis
Information provided by (Responsible Party):
Beata Banaszewska, Poznan University of Medical Sciences Identifier:
First received: October 31, 2012
Last updated: November 1, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)